Titre:
  • Poor Antibody Response to BioNTech/Pfizer Coronavirus Disease 2019 Vaccination in Severe Acute Respiratory Syndrome Coronavirus 2-Naive Residents of Nursing Homes.
Auteur:Pannus, Pieter; Neven, K.Y.; De Craeye, S.; Heyndrickx, Leo; Vande Kerckhove, Sara; Georges, Daphnée; Michiels, Johan; Francotte, Antoine; Van den Bulcke, Marc MVDB; Zrein, Maan; Gucht, Steven Van; Schmickler, Marie-Noëlle; Verbrugghe, Mathieu; Matagne, André; Thomas, Isabelle; Dierick, Katelijne; Martens Weiner, J. E.; Ackerman, Margaret M.E.; Goriely, Stanislas; Goossens, Maria M.E.; Ariën, Kevin; Desombere, Isabelle; Marchant, Arnaud
Informations sur la publication:Clinical infectious diseases, 75, 1, page (e695-e704)
Statut de publication:Publié, 2022-08-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:COVID-19
antibody response
immunosenescence
mRNA vaccination
nursing homes
MeSH keywords:Antibodies, Neutralizing
Antibodies, Viral
Antibody Formation
BNT162 Vaccine
COVID-19 -- prevention & control
Humans
Immunoglobulin G
Nursing Homes
RNA, Messenger
SARS-CoV-2
Vaccination
Vaccines, Synthetic
Viral Vaccines
mRNA Vaccines
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1058-4838
info:doi/10.1093/cid/ciab998
info:pii/6448839
info:scp/85144929348
info:pmid/34864935
PMC8690239